FibroBiologics to Spotlight Cell Therapy at H-SPAN Summit
Houston, Texas — February 10, 2026: FibroBiologics, Inc., a clinical-stage biotechnology company advancing fibroblast-based therapeutics, announced that its Chairman...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Houston, Texas — February 10, 2026: FibroBiologics, Inc., a clinical-stage biotechnology company advancing fibroblast-based therapeutics, announced that its Chairman...
Jupiter, Florida | January 28, 2026 — Jupiter Neurosciences, Inc., a clinical-stage pharmaceutical company, announced a strategic expansion of...
BOSTON, Massachusetts — January 12, 2026 — Junevity has announced the publication of its first peer-reviewed scientific study demonstrating...
